{"id":15531,"date":"2017-02-27T15:00:24","date_gmt":"2017-02-27T15:00:24","guid":{"rendered":"https:\/\/staging.rayner.com\/blog\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/"},"modified":"2024-11-11T16:01:10","modified_gmt":"2024-11-11T16:01:10","slug":"refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol","status":"publish","type":"post","link":"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/","title":{"rendered":"Refractive Cataract Chinese Surgeons Access Rayner IOL"},"content":{"rendered":"<p>For immediate release.<\/p>\n<p>March 02, 2017 \u2013 Worthing, United Kingdom. Rayner announced today that a selection of models in their\u00a0<a href=\"https:\/\/rayner.com\/global\/en\/iol\/supplementary\/\" target=\"_blank\" rel=\"noopener\">Sulcoflex\u00a0range<\/a>\u00a0of pseudophakic supplementary IOLs have received Chinese Food and Drug Administration (CFDA) approval and are to be launched in market in 2017.<\/p>\n<p><strong>Rayner is the first manufacturer to make a supplementary IOL available to surgeons in China.<\/strong><\/p>\n<p><strong>Product approval details<br \/>\n<\/strong><br \/>\nThe CFDA granted regulatory approval and sale of the following Sulcoflex\u00a0IOLs:<\/p>\n<ul>\n<li><a href=\"https:\/\/rayner.com\/global\/en\/iol\/supplementary\/sulcoflex-aspheric\/\" target=\"_blank\" rel=\"noopener\">Sulcoflex Aspheric<\/a><\/li>\n<li><a href=\"https:\/\/rayner.com\/global\/en\/iol\/supplementary\/sulcoflex-toric\/\" target=\"_blank\" rel=\"noopener\">Sulcoflex\u00a0Toric<\/a><\/li>\n<\/ul>\n<p>The IOLs are available through Beijing Cambridge, Rayner\u2019s exclusive IOL distributor in China since 2002.<\/p>\n<p>Rayner Sulcoflex\u00a0Pseudophakic Supplementary IOLs are designed to be implanted in the ciliary sulcus to correct residual post-operative refractive errors following the implantation of a conventional IOL in the capsular bag.<\/p>\n<p><strong>Rayner Commercial Director Cary Dawes<\/strong>\u00a0said: \u201cAfter a four year registration application \u2013 the longest in the history of Rayner \u2013 the CFDA has confirmed its approval of this selection of Sulcoflex\u00a0IOLs. This innovation has been successfully implanted for ten years and we are excited about launching it in a market as important as China. China is Rayner\u2019s number one distributor market in terms of size and growth, so to add the Sulcoflex\u00a0platform to our offering will open up even more growth opportunities.\u201d<\/p>\n<p>In addition to the Sulcoflex\u00a0range of pseudophakic supplementary IOLs, Rayner also offers a primary IOL portfolio which consists of\u00a0monofocal,\u00a0toric,\u00a0multifocal and multifocal-toric\u00a0IOLs.<\/p>\n<p>For further information regarding the availability of Sulcoflex, or any other products in the\u00a0<a href=\"https:\/\/rayner.com\/global\/\" target=\"_blank\" rel=\"noopener\">Rayner portfolio<\/a>, please contact your local sales representative or distributor.<\/p>\n<p><strong>[ENDS]<\/strong><\/p>\n<p>Rayner is a leading developer and\u00a0manufacturer\u00a0of ophthalmic implants and pharmaceuticals. When Sir Harold Ridley designed the world\u2019s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention.<\/p>\n<p>With more than 65 years of continuous growth and experience, we remain at the forefront of innovation. We are focused on providing the best visual outcomes for clinicians and patients and are driven by science to improve performance and safety.<\/p>\n<p>Headquartered in Worthing, United Kingdom, Rayner markets its IOL portfolio and related products worldwide in over 80 countries through a network of distributors and includes direct sales teams in the United Kingdom, USA, Germany &amp; Austria, Italy and Spain.<\/p>\n<p>For general enquiries, please contact Rayner: <a href=\"mailto:iol_enquiries@rayner.com\">iol_enquiries@rayner.com<\/a><\/p>\n<p>Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>For immediate release. March 02, 2017 \u2013 Worthing, United Kingdom. Rayner announced today that a selection of models in their\u00a0Sulcoflex\u00a0range\u00a0of pseudophakic supplementary IOLs have received Chinese Food and Drug Administration (CFDA) approval and are to be launched in market in 2017. Rayner is the first manufacturer to make a supplementary IOL available to surgeons in<\/p>\n","protected":false},"author":300,"featured_media":14246,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[942,945,949],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Chinese Surgeons Get Supplementary IOL | Rayner Global<\/title>\n<meta name=\"description\" content=\"Refractive cataract surgeons in China can now access Rayner\u2019s supplementary IOL, improving surgical and patient outcomes in cataract care.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chinese Surgeons Get Supplementary IOL | Rayner Global\" \/>\n<meta property=\"og:description\" content=\"Refractive cataract surgeons in China can now access Rayner\u2019s supplementary IOL, improving surgical and patient outcomes in cataract care.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/\" \/>\n<meta property=\"og:site_name\" content=\"Rayner : Brazil\" \/>\n<meta property=\"article:published_time\" content=\"2017-02-27T15:00:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-11T16:01:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/14882076241258136055.png\" \/>\n\t<meta property=\"og:image:width\" content=\"250\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"amber\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"amber\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/\",\"url\":\"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/\",\"name\":\"Chinese Surgeons Get Supplementary IOL | Rayner Global\",\"isPartOf\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/14882076241258136055.png\",\"datePublished\":\"2017-02-27T15:00:24+00:00\",\"dateModified\":\"2024-11-11T16:01:10+00:00\",\"author\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf\"},\"description\":\"Refractive cataract surgeons in China can now access Rayner\u2019s supplementary IOL, improving surgical and patient outcomes in cataract care.\",\"breadcrumb\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/#primaryimage\",\"url\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/14882076241258136055.png\",\"contentUrl\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/14882076241258136055.png\",\"width\":250,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/rayner.com\/br-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Refractive Cataract Chinese Surgeons Access Rayner IOL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#website\",\"url\":\"https:\/\/rayner.com\/br-pt\/\",\"name\":\"Rayner : Brazil\",\"description\":\"Rayner is a British manufacturer of ophthalmic medical products, including intraocular lenses (IOLs) and eye drops to support ocular health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rayner.com\/br-pt\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf\",\"name\":\"amber\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g\",\"caption\":\"amber\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chinese Surgeons Get Supplementary IOL | Rayner Global","description":"Refractive cataract surgeons in China can now access Rayner\u2019s supplementary IOL, improving surgical and patient outcomes in cataract care.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/","og_locale":"en_GB","og_type":"article","og_title":"Chinese Surgeons Get Supplementary IOL | Rayner Global","og_description":"Refractive cataract surgeons in China can now access Rayner\u2019s supplementary IOL, improving surgical and patient outcomes in cataract care.","og_url":"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/","og_site_name":"Rayner : Brazil","article_published_time":"2017-02-27T15:00:24+00:00","article_modified_time":"2024-11-11T16:01:10+00:00","og_image":[{"width":250,"height":200,"url":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/14882076241258136055.png","type":"image\/png"}],"author":"amber","twitter_card":"summary_large_image","twitter_misc":{"Written by":"amber","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/","url":"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/","name":"Chinese Surgeons Get Supplementary IOL | Rayner Global","isPartOf":{"@id":"https:\/\/rayner.com\/br-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/#primaryimage"},"image":{"@id":"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/#primaryimage"},"thumbnailUrl":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/14882076241258136055.png","datePublished":"2017-02-27T15:00:24+00:00","dateModified":"2024-11-11T16:01:10+00:00","author":{"@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf"},"description":"Refractive cataract surgeons in China can now access Rayner\u2019s supplementary IOL, improving surgical and patient outcomes in cataract care.","breadcrumb":{"@id":"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/#primaryimage","url":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/14882076241258136055.png","contentUrl":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/14882076241258136055.png","width":250,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/rayner.com\/br-pt\/refractive-cataract-surgeons-in-china-can-now-access-a-supplementary-iol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rayner.com\/br-pt\/"},{"@type":"ListItem","position":2,"name":"Refractive Cataract Chinese Surgeons Access Rayner IOL"}]},{"@type":"WebSite","@id":"https:\/\/rayner.com\/br-pt\/#website","url":"https:\/\/rayner.com\/br-pt\/","name":"Rayner : Brazil","description":"Rayner is a British manufacturer of ophthalmic medical products, including intraocular lenses (IOLs) and eye drops to support ocular health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rayner.com\/br-pt\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf","name":"amber","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g","caption":"amber"}}]}},"_links":{"self":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15531"}],"collection":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/users\/300"}],"replies":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/comments?post=15531"}],"version-history":[{"count":4,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15531\/revisions"}],"predecessor-version":[{"id":24031,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15531\/revisions\/24031"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/media\/14246"}],"wp:attachment":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/media?parent=15531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/categories?post=15531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/tags?post=15531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}